BioCryst has also filed its line extension application for the use of ORLADEYO oral granules in patients with HAE aged 2 to 11 years with the European Medicines Agency. Additional regulatory filings ...

The North Carolina Biotechnology Center’s newly relaunched Career Center site is now fully automated. On one recent day, the site listed nearly 2,000 jobs – about 15 times more jobs than the previous ...

The Translational Research Grant (TRG) program funds projects that explore commercial applications or initiate the early commercial development of university-held life sciences inventions. The ...

Grifols, already the largest private employer in Johnston County, is about to get even bigger. The Spanish biotherapeutics company is investing $210 million in two new facilities at its manufacturing ...

Fortune 500 medical technology firm Stryker (NYSE: SYK), based in Kalamazoo, Michigan, has acquired Durham-based HyperBranch Medical Technology, Inc., for $220 million. HyperBranch CEO Jeff Clark has ...

When singer songwriter Joni Mitchell wrote “...you don’t know what you’ve got ‘til it’s gone,” she didn’t know Thomas F. Tedder, Ph.D. Tedder, the Alter Geller Professor for Research in Immunology at ...

As the trade association for North Carolina’s life sciencesindustry, the NC Life Sciences Organization™ advances the industry and ecosystem and enables its members to innovate and collaborate for ...

2025 is shaping up to be a game-changer for AI in marketing. Join us on May 27 for a hybrid event, featuring a panel discussion on how AI is impacting life sciences marketing. This event is structured ...

Pappas Capital, a Durham-based investor in early-stage life sciences companies, has appointed Karen LeVert as venture partner. She will help expand the firm’s Specialized Fund Management business – ...

Locus Biosciences is a fast-emerging North Carolina biotechnology company that’s about to get a lot faster at unfolding its Pac-Man-like genetic tricks to whack drug-resistant bacteria. The Research ...